Skip to main content
. Author manuscript; available in PMC: 2024 Nov 1.
Published in final edited form as: Mol Genet Metab. 2023 Sep 11;140(3):107699. doi: 10.1016/j.ymgme.2023.107699

Table 2:

Association between clinical covariates, PBA metabolite concentrations, and PBA metabolite ratios. All statistically significant associations have been marked in bold font.

Variable No. Observations Value Unadjusted Linear Regression Result (p-value)
logPAA logPBA logPAGN log(PAA:PAGN)
Mean (SD) age at first assay (years) 68 14.7 (14.8) 0.0212 0.4088 0.1064 0.0404
Mean (SD) body surface area m2 68 1.1 (0.6) 0.0032 0.6787 0.0799 0.0036
Diagnosis N (%) 68 CPS1D 4 (5.9) 0.0616 0.3435 0.1404 0.0599
OTCD 32 (47.1)
ASS1D 15 (22.1)
ASLD 4 (5.9)
ARG1D 10 (14.7)
Others 3 (4.4)
Mean (SD) GPB dose in g/m2/day 68 4.9 (4.6) 0.1243 0.4966 0.4639 0.0867
Mean (SD) NaPBA dose in g/m2/day 68 3.4 (4.8) 0.0019 0.3315 0.0401 0.0042
Mean (SD) Ammonia μmol/L 46 34.4 (74.2) 0.7397 0.4809 0.2871 0.6929
Mean (SD) AST U/L 43 53.5 (40.8) 0.7901 0.8684 0.3973 0.6485
Mean (SD) ALT U/L 43 93.4 (147.1) 0.3319 0.4976 0.4519 0.0179
Mean (SD) GGT U/L 7 49.7 (47.0) 0.0883 0.5375 0.3547 0.0144
Mean (SD) Glutamine μmol/L 62 610.4 (261.2) 0.0019 0.9903 0.0428 0.0013
Mean (SD) Glycine μmol/L 62 249.0 (110.4) 0.0042 0.3528 0.0652 0.0026